Kazuistiky v diabetologii 14, MS1: 21–23, 2016.)
Keywords: type 2 diabetes mellitus, metformin, dapagliflozin, inhibitors SGLT2, gliflozins (Štechová, K., Koutek, J. What is still “normal” eating behavior in a patient with type 1 diabetes mellitus and what is not “normal” any more? Kazuistiky v diabetologii 14, 1: 30–33, 2016.)